A 6-month open-label study of the effectiveness and tolerability of galantamine in patients with Alzheimer's disease
- C.E. Patterson
- , A.P. Passmore
- , V.L.S. Crawford
Research output: Contribution to journal › Article › peer-review
15
Link opens in a new tab
Citations
(Scopus)